Health care costs remain a challenge despite advancements in the field. The use of GLP-1 medications has been linked to declining obesity rates, but these drugs may also increase health care costs. Artificial intelligence is being used to analyze costly claims and guide patients through the system.

Michael Wahlstrom and Dr. Stephen Palte, leaders at UnitedHealthcare, recently discussed these issues at a CEO Leadership Luncheon. The event took place on September 3 and featured the two experts addressing the complexities of the health care system.

Further details about the discussion and the impact of health care advancements on costs are available from the source.